Mipomerson collapses #Cholesterol, but cardiac events if anything worse? Ooops.

June 13th 2015 Update – listen to this guy before reading post (grey-bearded guy in vid on right hand side of page: “Strong reduction CV events in FH patients with ApoB-inhibitor”):  http://linkis.com/www.pace-cme.org/d/1/G6zQW

Original Post:  Interesting little study here on Mipomerson drug, useful to drive down cholesterol mercilessly in statin-resistant hypercholesterolemia peeps. And it does, even drives down the much-maligned ApoB !  But there’s a problem – what if you hammer ApoB into the ground, and your cardiac events don’t change, if anything worsen if you look at broad search and include negative cardiac side effects ? Ooops. Remember, ApoB is just an associative risk factor after all – Insulin is far more important ๐Ÿ˜‰ . The paper summary:

Mipomerson Mess

Excerpt of cholesterol huge reductions:

And the result:

And some side-effect fun:


Share This

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email
Subscribe to the NewsletterGuaranteed no spam stuff, just great unbiased health science โ€“ thanks for joining up !